{"id":5032,"date":"2024-04-26T13:10:34","date_gmt":"2024-04-26T11:10:34","guid":{"rendered":"https:\/\/www.redmedcapital.com\/?p=5032"},"modified":"2024-10-18T10:46:29","modified_gmt":"2024-10-18T08:46:29","slug":"eriser-entame-une-nouvelle-phase-de-son-developpement-en-accueillant-dans-son-capital-le-fonds-colombus-1-de-red-med-private-equity-2","status":"publish","type":"post","link":"https:\/\/www.redmedcapital.com\/en\/2024\/04\/26\/eriser-entame-une-nouvelle-phase-de-son-developpement-en-accueillant-dans-son-capital-le-fonds-colombus-1-de-red-med-private-equity-2\/","title":{"rendered":"ERISER is entering a new phase of its development by welcoming the Colombus 1 fund from Red Med Private Equity into its capital."},"content":{"rendered":"

Private Equity: ERISER Embarks on a New Phase of Development by Welcoming the Colombus 1 Fund from Red Med Private Equity<\/p>\n

ERISER is embarking on a new phase of its development by welcoming the Colombus 1 investment fund, an OPCC dedicated to supporting national entrepreneurs, SMEs, and ETMs in their development projects, into its capital.<\/p>\n

ERISER, a pioneering company in the field of irrigation, has established itself over its 32 years of existence as a reference in water management. ERISER chose excellence early on by establishing one of Morocco’s most advanced hydraulic and technical study departments and has been instrumental in the technological leap in irrigation professions in the country by consistently staying at the forefront of irrigation and water management technologies.<\/p>\n

Through this investment, Red Med Private Equity aims to leverage ERISER’s expertise in managing large hydraulic projects and equip the company with the means to address the entire water value chain. “Through this investment, the Colombus 1 Fund is aligned with national initiatives to manage risks related to water stress by providing ERISER with financial, industrial, and technological capacities, enabling the company to strengthen its national and regional presence in localized irrigation, drinking water management, hydromechanical equipment, pumping stations, solar pumping, and desalination,” said Abdeslam Ababou, president of Red Med Private Equity.<\/p>\n

The development project also includes an industrial integration of ERISER, allowing it to gain autonomy and the necessary capabilities to accelerate the growth of its activities. “The industrial integration project will enable ERISER to internalize the production of nearly 35% of its equipment and input purchases, thus increasing its level of autonomy and its ability to tackle a broader spectrum of hydraulic and water-related projects,” said Mr. Zouhair Seffar, founder and CEO of ERISER.<\/p>\n

Furthermore, the Colombus 1 fund aims to support the company’s institutionalization process while strengthening its DNA as a family-run, environmentally responsible, and socially committed company. “Beyond the strategic and financial rationale, our investment also seeks to support ERISER in its transition towards the highest operational and governance standards, implement an ESG strategy, and ultimately position ERISER as a national and regional leader in water-related project management,” said Mohamed Nasset, Managing Director of Red Med Private Equity.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>

<\/div>
<\/div><\/div><\/div>

Read more<\/span><\/span><\/h3><\/div><\/div><\/div>
\"\"<\/a><\/div><\/div><\/div><\/div>
\"\"<\/a><\/div><\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>","protected":false},"excerpt":{"rendered":"Private Equity: ERISER Embarks on a New Phase of Development by Welcoming the Colombus 1 Fund from Red Med Private Equity ERISER is embarking on a new phase of its development by welcoming the Colombus 1 investment fund, an OPCC dedicated to supporting national entrepreneurs, SMEs, and ETMs in their development projects, into its capital....","protected":false},"author":3,"featured_media":5029,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"footnotes":""},"categories":[3],"tags":[],"class_list":["post-5032","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualites"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.redmedcapital.com\/en\/wp-json\/wp\/v2\/posts\/5032","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.redmedcapital.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.redmedcapital.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.redmedcapital.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.redmedcapital.com\/en\/wp-json\/wp\/v2\/comments?post=5032"}],"version-history":[{"count":4,"href":"https:\/\/www.redmedcapital.com\/en\/wp-json\/wp\/v2\/posts\/5032\/revisions"}],"predecessor-version":[{"id":5737,"href":"https:\/\/www.redmedcapital.com\/en\/wp-json\/wp\/v2\/posts\/5032\/revisions\/5737"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.redmedcapital.com\/en\/wp-json\/wp\/v2\/media\/5029"}],"wp:attachment":[{"href":"https:\/\/www.redmedcapital.com\/en\/wp-json\/wp\/v2\/media?parent=5032"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.redmedcapital.com\/en\/wp-json\/wp\/v2\/categories?post=5032"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.redmedcapital.com\/en\/wp-json\/wp\/v2\/tags?post=5032"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}